Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome

Launched by AHMED ALSHIMY · Aug 5, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how neuromodulation, a treatment that aims to alter nerve activity, affects pain and daily functioning in people with fibromyalgia syndrome. Fibromyalgia is a chronic condition that causes widespread pain and can often make daily activities difficult. The researchers want to see if this treatment can help reduce pain and improve patients' quality of life.

To be eligible for this study, participants should be between 25 and 35 years old and have been diagnosed with fibromyalgia for at least six months. They must be medically stable and able to understand instructions. However, individuals with certain conditions, such as neurological diseases, pregnancy, or severe psychiatric disorders, cannot participate. If you join the trial, you can expect to receive the neuromodulation treatment and be monitored throughout the study to see how it impacts your pain and overall function. This trial is currently recruiting participants, so if you or someone you know meets the criteria, this could be an opportunity to explore new treatment options for fibromyalgia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients fibromyalgia from both genders.
• • 2. The duration of fibromyalgia is more than 6 month (all patients with history of cervical or lumbar pain) and following diagnosis of FM using the 2016 revised FM criteria, on the basis of the ACR-2010 criteria.
• • 3. Their ages will be ranged from 25-35 years old.
• • 4. They will be medically stable and have sufficient cognitive abilities that enable them to understand and follow instruction according to Montreal Cognitive Assessment (MoCA) \>26.
• Exclusion Criteria:
• • 1. Other Neurological diseases as stroke , multiple sclerosis, Parkinson's disease and motor neuron disease
• • 2. Pacemaker
• • 3. Spinal fusion-cervical or lumbar
• • 4. Metal implants in the spine
• • 5. Pregnancy
• • 6. Epilepsy
• • 7. Severe psychiatric disorder or alcohol and drug abuse.
• • 8. Unstable medical condition which could compromise the participant's welfare or confound the study results.
• • 9. Uncontrolled blood pressure or diabetes
• • 10. Visual or auditory problems.
• • 11. Active inflammatory conditions